Abstract
BackgroundThymic epithelial tumors (TET) are frequently eligible for curative‐intent surgical resection. For locally advanced TETs, chemotherapy has been used to both reduce the tumor burden and achieve prolonged disease control. However, effective therapy for this disease largely remains to be determined. Here, we report the chemosensitivity of 100 patients with TETs determined by the collagen gel droplet embedded culture‐drug sensitivity test (CD‐DST).MethodsA total of 100 patients with TETs underwent surgical resection. The efficacy of antitumor agents on TET cells was tested by CD‐DST.ResultsThymic epithelial tumors were pathologically confirmed after surgery: two cases were type A thymoma, 17 were type AB, 12 were type B1, 44 were type B2, 12 were type B3, and there were 13 cases with thymic carcinoma. A total of 36% patients with TETs were sensitive to different types of chemotherapeutic agents. There was no significant differences in age, histological type, clinical staging, or association with autoimmune diseases between sensitive and nonsensitive cases. Type B1 and B2 thymoma were relatively more sensitive to chemotherapeutic agents (6/12 and 18/44, respectively), while sensitivity of type B3 cases to chemotherapeutic agents was much lower (only 2/12). Cases with type A thymoma were not sensitive to any antitumor drugs. Among 11 chemotherapeutic agents tested in our study, the sensitivity of TETs to EPI was the highest (16%). No patients with thymoma were sensitive to Alimta (Pemetrexed).ConclusionsOur work illuminates the effectiveness of chemotherapy for TETs and provides important clues for choosing antitumor drugs with relatively high drug sensitivity to TETs in advance.
Highlights
Thymic epithelial tumors (TETs) represent the most common anterior mediastinal compartment neoplasm, originating from the epithelial cell population in the thymus
We report on the chemosensitivity of 100 patients with TETs by culture-drug sensitivity test (CD-DST)
One thymoma patient was associated with myasthenia gravis (MG) and acute promyelocytic leukemia, one with systemic lupus erythematosus (SLE), one with dermatomyositis, one with MG and mammary cancer, 22 solely with MG, and one with multiautoimmune disorders
Summary
Thymic epithelial tumors (TETs) represent the most common anterior mediastinal compartment neoplasm, originating from the epithelial cell population in the thymus Due to their different histological types, TETs show different clinical characteristics. Some anticancer drugs have been reported to be effective in some cases of thymoma or thymic carcinoma.[6–9]. Former studies have indicated that the collagen gel droplet embedded culture-drug sensitivity test (CD-DST)[10] could approximate the clinical effect in different types of malignant tumors[11,12] and have a high predictive accuracy for. We report the chemosensitivity of 100 patients with TETs determined by the collagen gel droplet embedded culture-drug sensitivity test (CD-DST). There was no significant differences in age, histological type, clinical staging, or association with autoimmune diseases between sensitive and nonsensitive cases. Conclusions: Our work illuminates the effectiveness of chemotherapy for TETs and provides important clues for choosing antitumor drugs with relatively high drug sensitivity to TETs in advance
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call